Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy.
de Pauw
B E
BE
Rubin
R H
RH
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000276:immunology; D005334:Fever / Q000188:drug therapy / Q000209:etiology; D019337:Hematologic Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017053:Infection Control / Q000379:methods*; D009503:Neutropenia / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D007166:Immunosuppressive Agents